Trial Profile
A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Degarelix (Primary) ; Dutasteride (Primary) ; Enzalutamide (Primary) ; Prednisolone
- Indications Prostate cancer
- Focus Therapeutic Use
- 23 Jan 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 24 Jul 2014 New trial record